Market Analysis — Friday, January 23, 2026

Validated market price ~$451.14 with reported P/E ~36.70 on the market data—still the richest valuation multiple in our current portfolio. MSFT remains a top-tier compounder with exceptional competitive positioning (enterprise software + Azure + distribution for AI), so this is not a thesis break. This is a valuation/risk management trim: at a high multiple, forward returns are more vulnerable to multiple compression if growth normalizes or if AI monetization lags heavy capex. By trimming a small portion (5 shares), we reduce concentration in the most valuation-stretched holding while preserving a core stake, and we reallocate into GOOGL where we see a stronger intrinsic-value-to-price setup today.

Validated market price ~$234.34. The long-term thesis remains intact: AWS scale economics and a multi-year optimization runway in retail/logistics can support expanding operating income, with additional optionality from advertising and subscriptions. At today’s price, AMZN remains a credible long-duration compounder, but compared with GOOGL’s clearly lower multiple (and similarly strong business quality), GOOGL offers the better marginal risk-adjusted expected return today. We HOLD rather than add, maintaining exposure without increasing concentration in a name where forward returns can be more sensitive to capex intensity and competitive dynamics in cloud/AI-enabled commerce.

Validated market price ~$647.63. META remains a high-quality cash generator with strong operating leverage and ongoing buybacks that can compound per-share intrinsic value. However, at a reported P/E ~31.5 on the market data, the valuation is no longer the most attractive within our mega-cap set (notably versus GOOGL at a lower multiple). Persistent regulatory/headline risk and the possibility of ad-cycle volatility argue for holding—not adding—at this level. We HOLD because fundamentals and moat remain intact and there is no clear sell trigger (no evidence of structural engagement or monetization breakage), but we reallocate incremental dollars elsewhere.

Validated market price ~$235.07. COF remains a fundamentally solid, scaled consumer finance franchise (post-DFS integration) that adds diversification versus our tech-heavy book. While credit-cycle risk and charge-off volatility are the key long-duration risks (and can drive near-term drawdowns), current pricing does not appear euphoric versus our mega-cap tech holdings, and we are not seeing an intrinsic-value impairment signal that would justify an exit. We HOLD rather than add because financials are more macro/credit sensitive than our highest-conviction compounders and we prefer deploying marginal capital into higher-quality, lower-multiple tech (GOOGL) today.

INTC technicals indicate improving trend structure: MACD=0.370 (Buy) with MA50=45.97 (Buy) and MA200=40.22 (Buy). RSI(14)=46.439 is Neutral (not ideal), but price referenced at ~$54.32 (latest market movers quote) implies strong reclaim/extension above major MAs—often an early-stage momentum rotation signal. Position size kept moderate; manage with a tight trend stop (e.g., loss of MA50 or ~2*ATR once ATR is observed from subsequent sessions).

MU shows momentum confirmation on technicals: RSI(14)=62.026 (Buy) and MACD=6.960 (Buy), with MA50=345.31 (Buy) and MA200=293.71 (Buy) indicating a strong uptrend regime. Price referenced at ~$397.58 (latest market movers quote) is well above MA50/MA200, consistent with trend-following entry. Use ATR-based risk control; initial stop ~2*ATR below entry (ATR not provided on this snapshot—use nearest swing low/MA20 proxy if needed).

AMD closed $253.73 with strong trend alignment: RSI(14)=67.661 (Buy), MACD(12,26)=6.03 (Buy), and MA20=245.89, MA50=234.35, MA200=217.97 all signaling Buy with price above them. ADX(14)=15.336 is Neutral (trend not accelerating), but broad MA stack + positive ROC=9.408 supports continuation. Add modestly to avoid overextension risk near highs.

ANET closed $138.41. Momentum/trend confirm: RSI(14)=64.281 (Buy), MACD(12,26)=2.88 (Buy), ROC=8.54 (Buy). Price is above MA20=131.99 and MA50=129.98 (both Buy signals on the moving-average table). Maintain with a trailing stop approach (e.g., close below MA20 or ~2*ATR(14)=~6.7 below price).

BLK at $1,139.72 remains trend-supported: RSI(14)=54.88 (Neutral but >50), MACD(12,26)=5.26 (Buy), ADX(14)=24.094 (Buy/strength improving), ROC=2.688 (Buy). Moving averages/indicator consensus on the daily view remains Strong Buy—no breakdown signal; keep as lower-volatility trend anchor.

MRK at $109.18 (close) shows momentum deterioration on the technical dashboard: RSI(14)=45.108 (Neutral), MACD(12,26)=-0.10 (Sell), ADX(14)=27.811 (Sell on this signal set), and multiple indicator readings are negative (Ultimate Oscillator 30.881 Sell; Bull/Bear Power -0.632 Sell). With competition performance (-7.25%) we prioritize strong-trend allocations; lock gains and redeploy.

Price $239.68 (close) is below key long-term trend filter: MA200=257.15 (Sell) and MA100=250.25 (Sell). RSI(14)=44.44 (bearish/weak momentum) and trend strength is weak (ADX(14)=24.384 flagged Sell). Despite MACD(12,26)=0.21 (Buy), the longer-term downtrend and under-water position violate trend-following rules; exit and rotate.

Price $28.49 (close) is below prior thesis breakout level and has lost momentum. Daily technicals show RSI(14)=43.147 (Sell), MACD(12,26)=-0.17 (Sell), ADX(14)=21.199 (Neutral/weak trend), and moving averages consensus is Strong Sell (11 sell signals). Large position size (1100 sh) + weak trend = unacceptable downside risk for momentum book.

NOW has a clear catalyst: a multi-year strategic collaboration with OpenAI to embed frontier models into ServiceNow workflows (agentic AI, voice, computer-use automation). The stock bounced ~2.6% on the session and has a near-term catalyst with earnings expected Jan 28, 2026. Buying 100 shares to position for continued news momentum and an earnings re-rating.

NVDA remains the market’s AI bellwether. Fresh reporting indicates Nvidia is boosting its next-gen Vera Rubin platform performance to defend hyperscaler demand versus AMD’s Instinct roadmap—supportive for continued leadership perception. With tech/risk assets rebounding after macro de-escalation, I’m buying 40 shares to capture momentum.

META has strong upside-news flow: global rollout of ads on Threads (with reported ~400M MAUs) plus bullish analyst commentary framing it as undervalued vs mega-cap peers. Stock printed a high-momentum +~5.7% session, signaling active institutional bid; I’m buying 15 shares to ride the catalyst into upcoming big-tech earnings season.

Validated vs portfolio: currently holding 3 shares (avg cost ~$485.40); latest quote ~$449.36 after a strong +~4% move. Fresh catalyst: reports that Tesla began offering robotaxi rides in Austin without onboard safety monitors, plus continued autonomy/Optimus narrative (WEF comments). This is exactly the kind of news-driven momentum I want to press; adding 7 shares to bring position to 10 total.

Validated vs portfolio: holding 20 shares (avg cost ~$310.45) and latest quote ~$318.79. Despite a down session, AMAT remains supported by AI-driven semi capex and has a defined catalyst with next earnings expected around Feb 12, 2026. Recent analyst commentary/targets remain constructive; keep exposure rather than selling a winner on a routine pullback.

Validated vs portfolio: holding 250 shares (avg cost ~$133.06) and latest quote ~$133.80 (back above cost). Recent January analyst actions skew positive (multiple upgrades, including Barclays to Equal-Weight; B. Riley to Buy). With the position back to green and the next earnings catalyst still ahead (mid-February window previously tracked), I’ll hold for potential pre-earnings momentum rather than churn.

Validated vs portfolio: holding 5 shares (avg cost ~$226.82) and latest quote ~$228.09. CRM showed strong relative strength today (+~2.9% session), and company narrative remains tied to agentic AI adoption (Agentforce/Data Cloud momentum). I’m keeping exposure but not adding due to better near-term catalysts in other names.

Validated vs portfolio: holding 50 shares (avg cost ~$201.92) and latest quote ~$196.34. Geopolitical “relief rally” reduces the immediate defense-spend headline bid, and RTX has a near-term binary catalyst with Q4/FY25 earnings scheduled for Jan 27, 2026 (pre-market). With price already below cost and better upside setups elsewhere, I’m exiting rather than gambling into earnings.